Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan.

• Tác giả: Takemi Akahane, Shohei Asada, Yuki Fujimoto, Yukihisa Fujinaga, Jun-Ichi Hanatani, Satoshi Iwai, Kosuke Kaji, Mariya Kawanishi, Akane Kawasaki, Mayuko Kikuchi, Koh Kitagawa, Aritoshi Koizumi, Takahiro Kubo, Hiroyuki Masuda, Takuya Matsuda, Akira Mitoro, Tadashi Namisaki, Norihisa Nishimura, Kazutaka Ohoka, Shinya Sato, Akihiko Shibamoto, Masayoshi Takami, Misako Tanaka, Fumimasa Tomooka, Yuki Tsuji, Daisuke Watanabe, Nobuyuki Yorioka, Hitoshi Yoshiji
• Ngôn ngữ: eng
• Thông tin xuất bản: Australia : DEN open , 2025
• Bộ sưu tập: NCBI
• ID: 250627

Tóm tắt

OBJECTIVES: This study aimed to determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on the treatment of acute cholangitis caused by choledocholithiasis. METHODS: The Japanese government declared a state of emergency in April 2020 due to the COVID-19 pandemic. We retrospectively reviewed the medical records of 309 patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) for acute cholangitis caused by choledocholithiasis between April 2017 and December 2022. RESULTS: Patients were categorized into a pregroup ( CONCLUSIONS: Although our hospital provides tertiary care, the number of patients with cholangitis in good general condition and no underlying disease increased after the state of emergency declaration. The COVID-19 pandemic resulted in an increase in the number of single-stage endoscopic treatments and shortened hospital stays for patients with acute cholangitis caused by choledocholithiasis. No safety issues with ERCP were detected, even during the pandemic.